0 results for 'Valeant Pharmaceuticals International, Inc.'
Florida Suing Drug Company Over Stock Losses
Acting on its own, Florida will take on an international pharmaceutical company, alleging the state's pension fund lost more than $62 million in stock…
Eye Drop Class Action Revived by Third Circuit
A putative class action over the size of eye medicine drops dismissed by a federal judge for lack of standing has been revived by the U.S. Court of Appeals for the Third Circuit.
Ex-Staffer at Big Canadian Law Firm Faces Insider Trading Charges
The Ontario Securities Commission, a Canadian regulator, has charged former Davies Ward Phillips & Vineberg legal assistant Donna Hutchinson in Toronto with insider trading. Davies Ward is one of the largest law firms in Canada.
Former Valeant Executive Denied Reconsideration in Securities Fraud Suit
The former head of Valeant Pharmaceuticals International Inc.' s dermatology division was unable to convince a court to end a class action lawsuit accusing the generic drugmaker and its executives of engaging in a massive scheme to fraudulently inflate the company's stock prices.
Proposal for New Rx Pricing Sheriff Greeted With Skepticism
A proposal by the Democratic Party to create a new "price gouging enforcer" in the federal government to stop big price spikes in prescription medications—like the EpiPen—is being greeted by skepticism with health care law experts.
Bausch & Lomb Incorporated v. Mimetogen Pharmaceuticals, Inc., 14-CV-6640
Publication Date: 2017-07-07 Practice Area:
Industry: Court: U.S. District Court, Western District Judge: District Judge Frank Geraci Attorneys: For plaintiff: For defendant: Case number: 14-CV-6640
Quebec Firm's Partial Judgment in Suit Over Eye Treatment's Commercialization Exp
Growth Surge Ends at Debevoise, But Ex-Partners Return
Debevoise & Plimpton saw its gross revenue, profits per partner and revenue per lawyer and head count drop in 2016. The firm started off 2017 by bringing back former partner and litigation leader Mary Jo White as senior chair.
BioTime Appoints Industry Vet as First-Ever GC
Industry veteran Stephana Patton will fill the newly created general counsel position at BioTime Inc.
Ceresney, Back at Debevoise, Predicts Strong SEC Under Trump
As he returns to his old firm, Andrew Ceresney says the U.S. Securities and Exchange Commission won't lose momentum under Donald Trump's administration.TRENDING STORIES
More from ALM
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Carolyn Burbrink, Uber Director of Volume Mobility Safety and Insurance Litigation 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Vaishali Rao, Hinshaw & Culbertson Partner 1 minute read
Resources
Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now